World Lifestyler
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
No Result
View All Result
WORLD LIFESTYLER
No Result
View All Result
Home Press Releases Press Releases - Lifestyle

Clinical Trial Media Strengthens Platform Leadership to Deliver Faster, More Predictable Enrollment Outcomes with Appointment of Paul Sternhell as Chief Product Officer

Cision PR Newswire by Cision PR Newswire
April 15, 2026
in Press Releases - Lifestyle
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

HAUPPAUGE, N.Y., April 15, 2026 /PRNewswire/ — Clinical Trial Media (CTM), a leading full‑service patient recruitment and retention partner to pharmaceutical and biotechnology companies, today announced that Paul Sternhell has joined the company as Chief Product Officer, strengthening CTM’s ability to deliver predictable, accountable enrollment performance across complex global clinical trials.


CTM Circle logo

In this role, Sternhell will lead the continued evolution of CTM’s technology platform, with a focus on improving enrollment speed, referral quality, and operational consistency for pharmaceutical and biotech companies. His appointment reflects CTM’s commitment to applying enterprise‑grade product discipline to one of clinical development’s most persistent challenges.

“Paul brings the right mix of platform, product, and operational experience for where CTM is today,” said Cara Brant, Chief Executive Officer of CTM. “He understands what it takes to scale enterprise technology with rigor and focus. As we continue to evolve our platform and work with an expanding set of pharma and biotech partners, his leadership will be an important part of our forward trajectory.”

“What drew me to CTM is the opportunity to apply proven enterprise product practices to a mission-driven healthcare challenge,” said Sternhell. “Clinical trials succeed or fail based on enrollment, and CTM sits at the center of solving one of the industry’s most persistent challenges. The company has the foundation, scale, and track record to build something truly differentiated, and I’m excited to help advance a platform that delivers stronger, more predictable trial performance.”

Sternhell brings deep experience building data-driven platforms and high-performing organizations at global technology companies, including Amazon Ads, Google, and GE. His leadership will further support CTM’s mission to reduce enrollment friction, improve referral quality, accelerate trial timelines, and enhance the experience for sponsors, sites, and patients, while maintaining end‑to‑end visibility across the enrollment lifecycle.

About Clinical Trial Media

Clinical Trial Media (CTM) is the largest full-service global patient enrollment organization, with three decades of experience supporting pharmaceutical and biotechnology sponsors. Combining proprietary technology with a dedicated in-house team of cross functional experts, CTM accelerates enrollment, expands patient access, reduces site burden, and provides a white-glove experience while matching patients to clinical research opportunities worldwide.

For more information, visit clinicaltrialmedia.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/clinical-trial-media-strengthens-platform-leadership-to-deliver-faster-more-predictable-enrollment-outcomes-with-appointment-of-paul-sternhell-as-chief-product-officer-302743234.html

SOURCE Clinical Trial Media

Cision PR Newswire

Cision PR Newswire

Related Posts

CCTV+: Hello, Beijing! Where Ancient Meets Modern

July 6, 2026

Share buybacks in Ericsson during the period June 29 – July 3, 2026

July 6, 2026

Fidelity Special Values Plc – Appointment of Corporate Broker and Financial Adviser

July 6, 2026

Beyond Bilateral Rivalry: Experts Reassess the Role of China-U.S. Relations in Global Stability

July 6, 2026

IvyBears Surpasses 2.5 Million Subscribers and 40 Million Views, Expanding Its Global Kids & Family Universe

July 6, 2026

MSFT Investors Have Opportunity to Lead Microsoft Corporation Securities Fraud Lawsuit

July 6, 2026

Popular News

  • PROSUS N.V. ANNOUNCES CASH TENDER OFFERS FOR ANY AND ALL OF ITS 4.850% NOTES DUE 2027 AND FOR UP TO THE CAPPED MAXIMUM AMOUNT OF ITS 3.257% NOTES DUE 2027

    0 shares
    Share 0 Tweet 0
  • Techstars and Emirates NBD partner to accelerate enterprise-grade AI and FinTech solutions across the MENAT region

    0 shares
    Share 0 Tweet 0
  • CCTV+: Hello, Beijing! Where Ancient Meets Modern

    0 shares
    Share 0 Tweet 0
  • UK CONSULTING SECTOR CEMENTS GLOBAL LEADERSHIP POSITION AS EXPORTS INCREASE BY 9%

    0 shares
    Share 0 Tweet 0
  • Share buybacks in Ericsson during the period June 29 – July 3, 2026

    0 shares
    Share 0 Tweet 0

About & Contact

  • About Us
  • Branding Style Guide
  • Contact Us
  • Help Centre
  • Media Kit
  • Site Map

Explore Content

  • Events
  • Newsletter
  • Press Releases
  • Topics

Legal & Privacy

  • Advertiser & Partner Policy
  • Communications & Newsletter Policy
  • Contributor Agreement
  • Copyright Policy
  • Privacy Policy
  • Prohibited Content Policy
  • Terms of Service

Tiny Media Brands

  • Silicon Valleys Journal
  • The AI Journal
  • The City Banker
  • The Wall Street Banker
  • World Lifestyler

© 2025 World Lifestyler

No Result
View All Result
  • Home

© 2025 World Lifestyler